Milestone Payments
ABVC BioPharma Receives $100,000 Milestone Payment in Vitargus Licensing Deal
ABVC BioPharma's latest milestone payment from ForSeeCon Eye Corporation strengthens a licensing agreement potentially worth $63.5 million for Vitargus®, positioning the company to capitalize on the multi-billion dollar global vitreous substitute market.
ABVC BioPharma Receives $100,000 Milestone Payment from OncoX BioPharma, Strengthening Oncology Partnership
ABVC BioPharma's latest milestone payment from OncoX BioPharma underscores the growing commercial value of their oncology platform and the potential for global market expansion in botanical-based cancer treatments.
ABVC BioPharma Achieves $100,000 Licensing Milestone with ForSeeCon, Enhancing Ophthalmology Focus
ABVC BioPharma's recent $100,000 milestone payment from ForSeeCon Eye Corporation underscores the growing commercial interest in its ophthalmology solutions, particularly Vitargus®, and strengthens its position in the global eye care market.
ABVC BioPharma Achieves $150K Milestone in Licensing Strategy, Highlighting Growth in Botanical Therapeutics
ABVC BioPharma's recent $150,000 milestone payment from AiBtl BioPharma underscores the success of its licensing-first strategy and the growing interest in its CNS-focused botanical therapeutics.